RT Journal
A1 Mitka M
T1 REsearchers still seek clinical benefit in raising levels of good cholesterol
JF JAMA
JO JAMA
YR 2012
FD January 4
VO 307
IS 1
SP 21
OP 22
DO 10.1001/jama.2011.1871
UL http://dx.doi.org/10.1001/jama.2011.1871
AB 
A hypothesis that is embraced by many in the medical community involves high-density lipoprotein cholesterol (HDL-C), the “good cholesterol.” Epidemiologic studies have found an inverse association between HDL-C levels and the rates of coronary heart disease events, so researchers theorize that raising HDL-C levels might reduce adverse coronary outcomes. However, proof of the theory remains outside researchers' grasp, as shown in studies presented at the American Heart Association's Scientific Sessions, held here in November.